These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11751114)

  • 1. Increased glycan chain length distribution and decreased susceptibility to moenomycin in a vancomycin-resistant Staphylococcus aureus mutant.
    Komatsuzawa H; Ohta K; Yamada S; Ehlert K; Labischinski H; Kajimura J; Fujiwara T; Sugai M
    Antimicrob Agents Chemother; 2002 Jan; 46(1):75-81. PubMed ID: 11751114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moenomycin-resistance is associated with vancomycin-intermediate susceptibility in Staphylococcus aureus.
    Nishi H; Komatsuzawa H; Yamada S; Fujiwara T; Ohara M; Ohta K; Sugiyama M; Ishikawa T; Sugai M
    Microbiol Immunol; 2003; 47(12):927-35. PubMed ID: 14695442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus.
    Nishi H; Komatsuzawa H; Fujiwara T; McCallum N; Sugai M
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4800-7. PubMed ID: 15561859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus.
    Sieradzki K; Tomasz A
    J Bacteriol; 1999 Dec; 181(24):7566-70. PubMed ID: 10601215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus.
    Sieradzki K; Pinho MG; Tomasz A
    J Biol Chem; 1999 Jul; 274(27):18942-6. PubMed ID: 10383392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of glycopeptide resistance in a highly teicoplanin-resistant mutant of Staphylococcus aureus by transposon inactivation of genes involved in cell wall synthesis.
    Sieradzki K; Tomasz A
    Microb Drug Resist; 1998; 4(3):159-68. PubMed ID: 9818967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcus aureus Penicillin-Binding Protein 2 Can Use Depsi-Lipid II Derived from Vancomycin-Resistant Strains for Cell Wall Synthesis.
    Nakamura J; Yamashiro H; Miya H; Nishiguchi K; Maki H; Arimoto H
    Chemistry; 2013 Sep; 19(36):12104-12. PubMed ID: 23873669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moenomycin resistance mutations in Staphylococcus aureus reduce peptidoglycan chain length and cause aberrant cell division.
    Rebets Y; Lupoli T; Qiao Y; Schirner K; Villet R; Hooper D; Kahne D; Walker S
    ACS Chem Biol; 2014 Feb; 9(2):459-67. PubMed ID: 24255971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus.
    Vaudaux P; Francois P; Berger-Bächi B; Lew DP
    J Antimicrob Chemother; 2001 Feb; 47(2):163-70. PubMed ID: 11157900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate.
    Boyle-Vavra S; Carey RB; Daum RS
    J Antimicrob Chemother; 2001 Nov; 48(5):617-25. PubMed ID: 11679550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.
    Hanaki H; Kuwahara-Arai K; Boyle-Vavra S; Daum RS; Labischinski H; Hiramatsu K
    J Antimicrob Chemother; 1998 Aug; 42(2):199-209. PubMed ID: 9738837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus.
    Sieradzki K; Tomasz A
    J Bacteriol; 1997 Apr; 179(8):2557-66. PubMed ID: 9098053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds.
    Pfeltz RF; Singh VK; Schmidt JL; Batten MA; Baranyk CS; Nadakavukaren MJ; Jayaswal RK; Wilkinson BJ
    Antimicrob Agents Chemother; 2000 Feb; 44(2):294-303. PubMed ID: 10639353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus.
    Moreira B; Boyle-Vavra S; deJonge BL; Daum RS
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1788-93. PubMed ID: 9257762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.
    Cui L; Lian JQ; Neoh HM; Reyes E; Hiramatsu K
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3404-13. PubMed ID: 16048954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.
    Tascini C; Flammini S; Leonildi A; Ciullo I; Tagliaferri E; Menichetti F
    J Chemother; 2012 Aug; 24(4):187-90. PubMed ID: 23040680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus.
    Cui L; Ma X; Sato K; Okuma K; Tenover FC; Mamizuka EM; Gemmell CG; Kim MN; Ploy MC; El-Solh N; Ferraz V; Hiramatsu K
    J Clin Microbiol; 2003 Jan; 41(1):5-14. PubMed ID: 12517819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin.
    Reipert A; Ehlert K; Kast T; Bierbaum G
    Antimicrob Agents Chemother; 2003 Feb; 47(2):568-76. PubMed ID: 12543661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
    Ghahremani M; Jazani NH; Sharifi Y
    J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prospective study of Staphylococcus aureus with reduced susceptibility to glycopeptides].
    Cantón R; Mir N; Martínez-Ferrer M; Sánchez del Saz B; Soler I; Baquero F
    Rev Esp Quimioter; 1999 Mar; 12(1):48-53. PubMed ID: 10896469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.